Abeona Therapeutics (ABEO) Equity Ratio (2016 - 2025)
Abeona Therapeutics (ABEO) has 15 years of Equity Ratio data on record, last reported at 0.74 in Q3 2025.
- For Q3 2025, Equity Ratio rose 95.21% year-over-year to 0.74; the TTM value through Sep 2025 reached 0.74, up 95.21%, while the annual FY2024 figure was 0.4, 74.49% up from the prior year.
- Equity Ratio reached 0.74 in Q3 2025 per ABEO's latest filing, up from 0.66 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.74 in Q3 2025 and bottomed at 0.12 in Q1 2024.
- Average Equity Ratio over 5 years is 0.42, with a median of 0.4 recorded in 2024.
- Peak YoY movement for Equity Ratio: crashed 133.78% in 2024, then skyrocketed 451.02% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.53 in 2021, then fell by 21.72% to 0.42 in 2022, then plummeted by 44.41% to 0.23 in 2023, then soared by 74.49% to 0.4 in 2024, then skyrocketed by 83.31% to 0.74 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.74 in Q3 2025, 0.66 in Q2 2025, and 0.42 in Q1 2025.